Terms: = Lymphoma AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Clinical Outcome
14 results:
1. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
2. CircEAF2 counteracts Epstein-Barr virus-positive diffuse large B-cell lymphoma progression via miR-BART19-3p/apc/β-catenin axis.
Zhao CX; Yan ZX; Wen JJ; Fu D; Xu PP; Wang L; Cheng S; Hu JD; Zhao WL
Mol Cancer; 2021 Dec; 20(1):153. PubMed ID: 34852843
[TBL] [Abstract] [Full Text] [Related]
3. Open-label, single arm, multicenter phase II study of VIDL induction chemotherapy followed by upfront autologous stem cell transplantation in patients with advanced stage extranodal NK/T-cell lymphoma.
Song GY; Yoon DH; Suh C; Moon JH; Baek DW; Kim JS; Lee GW; Yi JH; Park Y; Jung KS; Kim SJ; Yang DH; Kim WS
Bone Marrow Transplant; 2021 May; 56(5):1205-1208. PubMed ID: 33277620
[TBL] [Abstract] [Full Text] [Related]
4. Micro-RNA (miRNA) profile in Hodgkin lymphoma: association between clinical and pathological variables.
Paydas S; Acikalin A; Ergin M; Celik H; Yavuz B; Tanriverdi K
Med Oncol; 2016 Apr; 33(4):34. PubMed ID: 26951445
[TBL] [Abstract] [Full Text] [Related]
5. Concurrent infection of hepatitis B virus negatively affects the clinical outcome and prognosis of patients with non-Hodgkin's lymphoma after chemotherapy.
Chen J; Wang J; Yang J; Zhang W; Song X; Chen L
PLoS One; 2013; 8(7):e69400. PubMed ID: 23861969
[TBL] [Abstract] [Full Text] [Related]
6. clinical outcome of hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL): experience from a single institution.
Doki N; Ohashi K; Oshikawa G; Kobayashi T; Kakihana K; Sakamaki H
Pathol Oncol Res; 2014 Jan; 20(1):61-6. PubMed ID: 23821455
[TBL] [Abstract] [Full Text] [Related]
7. Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404).
Ganjoo K; Hong F; Horning SJ; Gascoyne RD; Natkunam Y; Swinnen LJ; Habermann TM; Kahl BS; Advani RH
Leuk Lymphoma; 2014 Apr; 55(4):768-72. PubMed ID: 23786456
[TBL] [Abstract] [Full Text] [Related]
8. Haploidentical bone marrow transplants for haematological malignancies using non-myeloablative conditioning therapy and post-transplant immunosuppression with cyclophosphamide: results from a single Australian centre.
Bilmon IA; Kwan J; Gottlieb D; Kerridge I; McGurgan M; Huang G; George B; Hertzberg M; Bradstock KF
Intern Med J; 2013 Feb; 43(2):191-6. PubMed ID: 22646924
[TBL] [Abstract] [Full Text] [Related]
9. Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation.
Griffiths EA; Gore SD; Hooker C; McDevitt MA; Karp JE; Smith BD; Mohammad HP; Ye Y; Herman JG; Carraway HE
Leuk Lymphoma; 2010 Sep; 51(9):1711-9. PubMed ID: 20795789
[TBL] [Abstract] [Full Text] [Related]
10. TCRgamma-chain gene rearrangement by GeneScan: incidence and significance of clonal heterogeneity in Sézary syndrome.
Fierro MT; Ponti R; Titli S; Bonello L; Comessatti A; Novelli M; Fava P; di Celle PF; Quaglino P; Bernengo MG
J Invest Dermatol; 2010 Sep; 130(9):2312-9. PubMed ID: 20410915
[TBL] [Abstract] [Full Text] [Related]
11. Influence of low absolute lymphocyte count of patients with nongerminal center type diffuse large B-cell lymphoma with R-CHOP therapy.
Song MK; Chung JS; Seol YM; Kim SG; Shin HJ; Choi YJ; Cho GJ; Shin DH
Ann Oncol; 2010 Jan; 21(1):140-4. PubMed ID: 19887468
[TBL] [Abstract] [Full Text] [Related]
12. Granulocytic sarcoma: 32 cases and review of the literature.
Paydas S; Zorludemir S; Ergin M
Leuk Lymphoma; 2006 Dec; 47(12):2527-41. PubMed ID: 17169797
[TBL] [Abstract] [Full Text] [Related]
13. Prognostic significance of T-cell or cytotoxic molecules phenotype in classical Hodgkin's lymphoma: a clinicopathologic study.
Asano N; Oshiro A; Matsuo K; Kagami Y; Ishida F; Suzuki R; Kinoshita T; Shimoyama Y; Tamaru J; Yoshino T; Kitamura K; Fukutani H; Morishima Y; Nakamura S
J Clin Oncol; 2006 Oct; 24(28):4626-33. PubMed ID: 16954517
[TBL] [Abstract] [Full Text] [Related]
14. Idiotypic vaccination for B-cell malignancies as a model for therapeutic cancer vaccines: from prototype protein to second generation vaccines.
Ruffini PA; Neelapu SS; Kwak LW; Biragyn A
Haematologica; 2002 Sep; 87(9):989-1001. PubMed ID: 12217812
[TBL] [Abstract] [Full Text] [Related]